Recent research has demonstrated the presence of PD-L1 on the surface of TDEs from various malignancies, including head and neck squamous cell carcinoma, lung cancer, hypopharyngeal cancer, melanoma, and nasopharyngeal carcinoma (64–69). This evidence concerns the gene CD274 and melanoma.